Scientists have welcome news for the more than 2.3 million people across the globe who live with multiple sclerosis. According to researchers, a new breakthrough drug can help reduce symptoms, and delay progression of this painful and debilitating disease, even in people who do not respond to any other treatments.
The new drug is expected to be approved by the Food and Drug Administration (FDA) as early as March. The drug called OCREVUS has been found to significantly delay the progression of symptoms of the disease, and limit the extent of physical disability in people who suffer from primary progressive multiple sclerosis. The drug reduces the frequency of attacks in these people.
MS can be a difficult condition to treat, because it affects different people in different ways. The severity of symptoms may differ between two different people, and the rate of progression may also vary. Many people with multiple sclerosis respond to some of the treatment drugs that are available on the market. These drugs are designed to limit symptoms, limit the progression of the disease, and reduce the number of attacks.
People who suffer from relapsing MS have been found to be much more receptive to the drugs that are already available on the market. However, people who suffer from primary progressive multiple sclerosis are often frustrated by their lack of response to the drugs which are currently approved by the Food and Drug Administration and available on the market.
OCREVUS promises to change all that. The drug, according to researchers, targets the specific cells that are involved in the repair and damage of the myelin sheath.
The announcement by scientists is welcome news for persons who suffer from multiple sclerosis, and feel helpless as their condition deteriorates and their symptoms worsen.
If you suffer from multiple sclerosis, you may qualify for Social Security disability benefits. Speak to the best Atlanta Social Security disability attorney you can about your options for applying for assistance.